InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Rowland Thomas Andrew. Director active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 8 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €365k. History available since 15 November 2024. The latest transaction was filed on 14 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Rowland Thomas Andrew is a declarant linked to ANI Pharmaceuticals INC, where he holds the role of SVP, HEAD - ESTABLISHED BRANDS. He has 7 filings in total, and the 7 sampled filings span 2024-11-18 to 2026-02-17, with transaction amounts tied to tax withholding and individual amounts up to EUR 46585.43870024199.